Qube Research & Technologies LTD Axonics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 686,450 shares of AXNX stock, worth $48.4 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
686,450
Previous 571,246
20.17%
Holding current value
$48.4 Million
Previous $39.4 Million
17.14%
% of portfolio
0.07%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding AXNX
# of Institutions
230Shares Held
43MCall Options Held
50.2KPut Options Held
135K-
Vanguard Group Inc Valley Forge, PA5.04MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$306 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.18MShares$154 Million6.99% of portfolio
-
Fil LTD Hamilton, D02.04MShares$144 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$125 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.46B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...